
During the past year observations have been published that might lead to further improvement in the design of future clinical zzso At the same time, results of clinical trials have become available that suggest that a number of treatments could be of benefit in the care of patients in the various zzso of multiple zzso Future multiple sclerosis clinical trials should involve a blinded investigator restricted to assessing the clinical outcome zzso and because current evidence suggests that magnetic resonance imaging gives an objective and sensitive reflection of the biological evolution of the disease, such scanning should also be zzso The use of a composite outcome variable in a trial of chronic progressive multiple sclerosis should also be considered in order to increase the percentage of patients reaching the clinical zzso In 1994 recommendations were published for the selection of zzso patients for treatment with zzso zzso zzso large and well performed clinical trials demonstrated that zzso zzso and zzso are also partially effective, though not zzso for these zzso Two smaller studies suggested that zzso zzso and zzso might have a beneficial effect on the course of the disease in patients with secondary chronic progressive multiple zzso the former drug probably being less zzso Unfortunately, therapeutic perspectives for patients with primary progressive multiple sclerosis are less promising at zzso Several studies suggest that zzso and zzso have therapeutic potential for symptomatic zzso the former by improving neurological deficits, the latter by zzso troublesome zzso zzso AT 250 zzso 

